Browse
Submit Data
Databases
API
Help

Dataset Information

16 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tetra-phenyl piperazine-1,4-diyldiphos-pho-nate.

ABSTRACT: The mol-ecule of the title compound, C(28)H(28)N(2)O(6)P(2), is organized around an inversion center located at the centre of the piperazine ring. Both piperazine N atoms are substituted by P(O)(OC(6)H(5))(2) phospho-ester groups. The P atoms display a slightly distorted tetra-hedral environment; the N atoms show some deviation from planarity. The O atoms of the P=O groups are involved in inter-molecular C-H?O hydrogen bonds, building R(2) (2)(22) rings, in extended chains parallel to the a axis. C-H?? inter-actions involving the phenyl rings further stabilize the packing.

SUBMITTER: Pourayoubi M

PROVIDER: S-EPMC3011784 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

1-Phenyl-piperazine-1,4-diium tetra-chlorido-cobalt(II).

Project description:In the title mol-ecular salt, (C10H16N2)[CoCl4], the piperazine ring of the phenyl-piperazine dication adopts a chair conformation and the phenyl ring occupies an equatorial orientation. In the tetra-chlorido-cobaltate(II) dianion, the Co-Cl bond lengths for the chloride ions not accepting hydrogen bonds are significantly shorter than those for the chloride ions accepting such bonds. In the crystal, the components are linked by N-H⋯Cl hydrogen bonds, generating [001] chains.

| S-EPMC3998532 | biostudies-literature

2,3,5,6-Tetra-methoxy-piperazine-1,4-dicarbaldehyde.

Project description:The asymmetric unit of the title compound, C(10)H(18)N(2)O(6), contains two halves of two independent centrosymmetric mol-ecules with almost identical conformations. Weak inter-molecular C-H?O hydrogen bonds consolidate the crystal packing.

| S-EPMC2970317 | biostudies-literature

1-Methyl-piperazine-1,4-diium tetra-chloridozincate hemihydrate.

Project description:The crystal structure of the title compound, (C(5)H(14)N(2))[ZnCl(4)]·0.5H(2)O, is built up from discrete 1-methyl-piperazine-diium cations with chair conformation, tetrahedral tetrachloridozincate anions and uncoordinated solvent water mol-ecules linked together by three types of inter-molecular hydrogen bonds, viz. N-H?Cl, N-H?O and O-H?Cl.

| S-EPMC3247527 | biostudies-literature

1-Phenyl-piperazine-1,4-diium bis-(hydrogen sulfate).

Project description:In the title compound, C(10)H(16)N(2) (2+)·2HSO(4) (-), the S atoms adopt slightly distorted tetra-hedral geometry and the diprotonated piperazine ring adopts a chair conformation. In the crystal, the 1-phenyl-piperazine-1,4-diium cations are anchored between chains formed by the sulfate entities via inter-molecular bifurcated N-H?(O,O) and weak C-H?O hydrogen bonds. These hydrogen bonds contribute to the cohesion and stability of the network of the crystal structure.

| S-EPMC2983403 | biostudies-literature

Piperazine-1,4-diium bis-[tetra-chlorido-aurate(III)] dihydrate.

Project description:In the title compound, (C(4)H(12)N(2))[AuCl(4)](2)·2H(2)O, the Au(III) atom has a square-planar geometry. The piperazinium dication lies on an inversion centre and adopts a typical chair conformation. In the crystal, a combination of N-H?O, N-H?Cl and O-H?Cl hydrogen bonds results in the formation of a three-dimensional network.

| S-EPMC2971124 | biostudies-literature

Bis(1-methyl-piperazine-1,4-diium) tetra-chloridocuprate(II).

Project description:The title compound, (C(5)H(14)N(2))[CuCl(4)], was synthesized by hydro-thermal reaction of CuCl(2) with 1-methyl-piperazine in an HCl/water solution. Both amine N atoms are protonated. The piperazine ring adopts a chair conformation. The Cu-Cl distances in the tetrahedral anion are in the range 2.2360?(7)-2.2732?(7)?Å. In the crystal, moderately strong and weak inter-molecular N-H?Cl hydrogen bonds link the anion and cation units into an infinite two-dimensional network parallel to the ab plane.

| S-EPMC3152076 | biostudies-literature

(S)-1,2,4-Trimethyl-piperazine-1,4-diium tetra-chloridozincate(II).

Project description:In the title compound, (C(7)H(18)N(2))[ZnCl(4)], the Zn atom adopts a slightly distorted tetra-hedral geometry. The diprotonated piperazine ring adopts a chair conformation. In the crystal structure, the cations and anions are linked by inter-molecular N-H⋯Cl hydrogen bonds into a chain along [001].

| S-EPMC3007566 | biostudies-literature

(R)-2-Methyl-piperazine-1,4-diium diaqua-tetra-chloridoferrate(II).

Project description:In the title salt, (C(5)H(14)N(2))[FeCl(4)(H(2)O)(2)], the Fe(II) cation is coordinated by four Cl(-) anions and two water mol-ecules in a distorted octa-hedral geometry. The piperazine ring adopts a normal chair conformation. Inter-molecular N-H?Cl, N-H?(Cl,Cl) and O-H?Cl hydrogen bonding is present in the crystal structure.

| S-EPMC2983358 | biostudies-literature

Tris(piperazine-1,4-diium) bis-[hexa-chloridoindate(III)] tetra-hydrate.

Project description:The asymmetric unit of the title compound, (C(4)H(12)N(2))(3)[InCl(6)](2)·4H(2)O, consists of one and half independent piperazinium cations, an hexa-chloridoindate anion and two mol-ecules of water. The In(III) ion is six-coordinated and forms a quasi-regular octa-hedral arrangement. In the crystal, alternating layers of cations and anions are arranged parallel to (10[Formula: see text]) and are linked with the water mol-ecules via intra- and inter-molecular N-H⋯O, O-H⋯Cl, C-H⋯O and N-H⋯Cl hydrogen bonds, forming a complex three-dimensional network. Additional stabilization within the layers is provided by weak inter-molecular C-H⋯Cl inter-actions.

| S-EPMC3099932 | biostudies-literature

(R)-2-Methyl-piperazine-1,4-diium tetra-chloridoanti-monate(III) chloride.

Project description:In the complex anion of the title compound, (C(5)H(14)N(2))[SbCl(4)]Cl, the Sb atom is tetra-coordinate within a saw-horse configuration. The cation adopts a chair conformation. The crystal structure is stabilized by inter-molecular N-H?Cl hydrogen bonds.

| S-EPMC3011473 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data